Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Biomarkers

• Publication date

  2017-12-12

• Fields of study

  Biology, Medicine, Psychology

• Identifiers
  DOI 10.3233/CBM-170550PMID 29081411
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types

  2017cited by this paper
• Mitochondrial DNA plasticity is an essential inducer of tumorigenesis

  2016cited by this paper
• A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer

  2016cited by this paper
• Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients

  2016cited by this paper
• Anti-protozoal and anti-bacterial antibiotics that inhibit protein synthesis kill cancer subtypes enriched for stem cell-like properties

  2015cited by this paper
• Cancer statistics, 2015

  2015cited by this paper
• limma powers differential expression analyses for RNA-sequencing and microarray studies

  2015influential reference
• Apoptotic Effects of Novel Dithiocarbamate Analogs of Emetine in Prostate Cancer Cell Lines.

  2015cited by this paper
• Breast Cancer: Insights into Risk Factors, Pathogenesis, Diagnosis and Management

  2015cited by this paper
• STRING v10: protein–protein interaction networks, integrated over the tree of life

  2014cited by this paper
• RNA-seq analyses of multiple meristems of soybean: novel and alternative transcripts, evolutionary and functional implications

  2014cited by this paper
• Emetine dihydrochloride: a novel therapy for bladder cancer.

  2014cited by this paper
• Emetine enhances the tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of pancreatic cancer cells by downregulation of myeloid cell leukemia sequence-1 protein.

  2014cited by this paper
• Ribosomal Protein S14 Negatively Regulates c-Myc Activity*

  2013cited by this paper
• Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B.

  2012cited by this paper
• Treatment options for patients with triple-negative breast cancer

  2010cited by this paper
• Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer

  2009cited by this paper
• Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

  2008cited by this paper
• Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

  2008cited by this paper
• Alkaloids Induce Programmed Cell Death in Bloodstream Forms of Trypanosomes (Trypanosoma b. brucei)

  2008cited by this paper
• Gene expression profiling in women with breast cancer in a Saudi population.

  2008cited by this paper
• Inhibition of c‐Myc activity by ribosomal protein L11

  2007cited by this paper
• The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease

  2006cited by this paper
• Reduction of cytotoxicity of the alkaloid emetine through P-glycoprotein (MDR1/ABCB1) in human Caco-2 cells and leukemia cell lines.

  2006cited by this paper
• Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variables.

  2005cited by this paper
• PathwayVoyager: pathway mapping using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database

  2005cited by this paper
• The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation.

  2005cited by this paper
• Cancer Facts & Figures 2004

  2004cited by this paper
• affy - analysis of Affymetrix GeneChip data at the probe level

  2004cited by this paper
• Regulation of HDM2 activity by the ribosomal protein L11.

  2003cited by this paper
• Identification of ribosomal proteins S2 and L10a as tumor antigens recognized by HLA-A26-restricted CTL.

  2003cited by this paper
• An automated method for finding molecular complexes in large protein interaction networks

  2003cited by this paper
• Ribosomal Protein L11 Negatively Regulates Oncoprotein MDM2 and Mediates a p53-Dependent Ribosomal-Stress Checkpoint Pathway

  2003cited by this paper
• Exploration, normalization, and summaries of high density oligonucleotide array probe level data.

  2003cited by this paper
• Cytoscape: a software environment for integrated models of biomolecular interaction networks.

  2003cited by this paper
• c-MYC: more than just a matter of life and death

  2002cited by this paper
• Activation of the mitochondrial caspase cascade in the absence of protein synthesis does not require c-Jun N-terminal kinase.

  2002cited by this paper
• Gene expression profiles of pancreatic cancer and stromal desmoplasia

  2001cited by this paper
• The Myc/Max/Mad network and the transcriptional control of cell behavior.

  2000cited by this paper
• Gene Ontology: tool for the unification of biology

  2000cited by this paper
• MYC oncogenes and human neoplastic disease

  1999cited by this paper
• Csa-19, a radiation-responsive human gene, identified by an unbiased two-gel cDNA library screening method in human cancer cells

  1997cited by this paper
• Identification of genes downregulated in the thymus by cyclosporin-A: preliminary characterization of clone CSA-19.

  1995cited by this paper
• Formation of high molecular mass DNA fragments is a marker of apoptosis in the human leukaemic cell line, U937.

  1994cited by this paper
• Cancer statistics

  1989cited by this paper
• Inhibitors of protein biosynthesis. V. Effects of emetine on protein and nucleic acid biosynthesis in HeLa cells.

  1967cited by this paper
• STRUCTURAL BASIS FOR INHIBITION OF PROTEIN SYNTHESIS BY EMETINE AND CYCLOHEXIMIDE BASED ON AN ANALOGY BETWEEN IPECAC ALKALOIDS AND GLUTARIMIDE ANTIBIOTICS*

  1966cited by this paper

• Advances in prognostic and predictive biomarkers for breast cancer: Integrating multigene assays, hormone receptors, and emerging circulating biomarkers.

  2025cites this paper
• mTORC1-Driven Protein Translation Correlates with Clinical Benefit of Capivasertib within a Genetically Preselected Cohort of PIK3CA-Altered Tumors

  2024cites this paper
• Proteomic profiling of urinary extracellular vesicles differentiates breast cancer patients from healthy women

  2023cites this paper
• Robust Identification of Differential Gene Expression Patterns from Multiple Transcriptomics Datasets for Early Diagnosis, Prognosis, and Therapies for Breast Cancer

  2023cites this paper
• Microfluidic single-cell migration chip reveals insights into the impact of extracellular matrices on cell movement.

  2023cites this paper
• Integrative bioinformatics and RNA sequencing based methodology results in the exploration of breast invasive carcinoma biomarkers.

  2023cites this paper
• A Ribosome-Related Prognostic Signature of Breast Cancer Subtypes Based on Changes in Breast Cancer Patients’ Immunological Activity

  2023cites this paper
• Identification of genomic biomarkers and their pathway crosstalks for deciphering mechanistic links in glioblastoma

  2023cites this paper
• An AI Approach to Identifying Novel Therapeutics for Rheumatoid Arthritis

  2023cites this paper
• Identification of crucial hub genes and potential molecular mechanisms in breast cancer by integrated bioinformatics analysis and experimental validation

  2022cites this paper
• An integrative approach toward identification and analysis of therapeutic targets involved in HPV pathogenesis with a focus on carcinomas

  2022cites this paper
• Krüppel-like factor 7 influences translation and pathways involved in ribosomal biogenesis in breast cancer

  2022cites this paper
• RPS9 promotes the progression of NSCLC via activation Stat3 and Erk signaling pathways

  2022cites this paper
• Thorough statistical analyses of breast cancer co-methylation patterns

  2021cites this paper
• High expression of MCM10 is predictive of poor outcomes in lung adenocarcinoma

  2021cites this paper
• Quantitative Proteomic Profiling Identifies a Potential Novel Chaperone Marker in Resistant Breast Cancer

  2021cites this paper
• The Advantages of Connectivity Map Applied in Traditional Chinese Medicine

  2021cites this paper
• A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of Gelsemium elegans Benth against colorectal cancer

  2021cites this paper
• Mibefradil inhibits the proliferation of triple-negative breast cancer by targeting AURKA to regulate apoptosis signal pathway

  2021cites this paper
• A Novel 8-Gene Prognostic Signature for Survival Prediction of Uveal Melanoma

  2021cites this paper
• Identification of Potential Biomarkers and Their Pathways for Breast Cancer using Integrated Bioinformatics Analysis

  2020cites this paper
• Prognostic value of small nucleolar RNAs (snoRNAs) for colon adenocarcinoma based on RNA sequencing data.

  2020cites this paper
• Development and validation of a five‐lncRNA signature with prognostic value in colon cancer

  2020cites this paper
• Identification of ribosomal protein family in triple-negative breast cancer by bioinformatics analysis

  2020cites this paper
• Identification of mRNA and non-coding RNA hubs using network analysis in organ tropism regulated triple negative breast cancer metastasis

  2020cites this paper
• Expression of collagen type 1 alpha 1 indicates lymph node metastasis and poor outcomes in squamous cell carcinomas of the lung

  2020cites this paper
• LncRNA BRCAT54 inhibits the tumorigenesis of non-small cell lung cancer by binding to RPS9 to transcriptionally regulate JAK-STAT and calcium pathway genes.

  2020cites this paper
• Mechanism of Astragalus membranaceus in the treatment of laryngeal cancer based on gene co-expression network and molecular docking

  2020cites this paper
• Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis

  2019cites this paper
• A Network Pharmacology-Based Strategy For Predicting Active Ingredients And Potential Targets Of LiuWei DiHuang Pill In Treating Type 2 Diabetes Mellitus

  2019cites this paper
• Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis.

  2019cites this paper
• A Network Pharmacology-Based Strategy For Predicting Active Ingredients And Potential Targets Of LiuWei DiHuang Pill In Treating Type 2 Diabetes Mellitus

  2019cites this paper
• OTOR in breast carcinoma as a potent prognostic predictor correlates with cell proliferation, migration and invasion.

  2019cites this paper
• Identifying Key Genes of Liver Cancer by Networking of Multiple Data Sets

  2019cites this paper
• A Network Pharmacology-Based Strategy For Predicting Active Ingredients And Potential Targets Of LiuWei DiHuang Pill In Treating Type 2 Diabetes Mellitus

  2019cites this paper
• A Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of LiuWei DiHuang Pill in Treating Type 2 Diabetes Mellitus [Corrigendum]

  2019cites this paper
• Network pharmacology-based study on the mechanism of “Jiu Wei Zhu Huang San” in respiratory tract infections treatment

  2019cites this paper
• Mining conditions specific hub genes from RNA‐Seq gene‐expression data via biclustering and their application to drug discovery

  2019cites this paper
• Prognostic roles of the expression of sphingosine-1-phosphate metabolism enzymes in non-small cell lung cancer.

  2019cites this paper
• Identification of genes and analysis of prognostic values in nonsmoking females with non-small cell lung carcinoma by bioinformatics analyses

  2018cites this paper
• Identification of critically carcinogenesis-related genes in basal cell carcinoma

  2018cites this paper
• Identification of hub genes and outcome in colon cancer based on bioinformatics analysis

  2018cites this paper
• The Open Bioinformatics Journal

  year unknowncites this paper